United States· US:0703-3216_06be4aa9-891a-4a0c-aa09-01a3e87e559c

Paclitaxel

A paclitaxel product containing paclitaxel, registered in United States by Teva Parenteral Medicines, Inc.. The same ATC class is registered in 16 of our 19 countries.

ATC L01CD01

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPaclitaxelATCL01CD01REGISTER NO.US:0703-3216_06be4aa9…PACKS LISTED1CHECKEDSeptember 6, 2026

Where it is registered

Paclitaxel is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CD01 (paclitaxel), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Paclitaxel · ATC L01CD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paclitaxel costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.61 in Czechia to $19.82 in Switzerland — a ×32 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paclitaxel · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$19.82
  • CZ Czechia$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PACLITAXEL
Manufacturer
Teva Parenteral Medicines, Inc.
Country
United States (US)
ATC code
L01CD01
ATC class
Paclitaxel
Defined daily dose
15 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 6, 2026

Packs & prices · 1

  • ndc11
    0703-3216-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

651 interactions on record for paclitaxel.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paclitaxel · interactions on record

651 records

  • 41 severe
  • 302 moderate
  • 17 minor
  • 291 info

Most severe, free to view

  • SaquinavirJ05AE01severe
  • IndinavirJ05AE02severe
  • RitonavirJ05AE03severe
  • NelfinavirJ05AE04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paclitaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paclitaxel products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Apacross, Bugvi
  • Belgium · Apacross, Bugvi
  • Bulgaria · Алсикроса, Паклитаксел Акорд
  • Cyprus · Paclitaxel Accord, Paclitaxel Hospira
  • Czechia · Alsicrosa, Paclitaxel Ebewe
  • Germany · Apacross, Axitaxel
  • Denmark · Apacross, Bugvi
  • Estonia · Paclitaxel Accord, Paclitaxel Ebewe
  • Spain · Apacross, Bugvi
  • Finland · Apacross, Pacligen
  • France · Bugvi, Paclitaxel Ahcl
  • United Kingdom (Northern Ireland) · Apacross, Paclitaxel
  • Greece · Biotaxel, Paclitaxel Hospira
  • Croatia · Abutrax, Alsicrosa
  • Hungary · Bugvi, Paclitaxel Accord
  • Ireland · Apacross, Paclitaxel
  • Iceland · Abraxane, Apexelsin
  • Italy · Abutrax, Apacross
  • Liechtenstein · Abraxane, Apexelsin
  • Lithuania · Paclitaxel Accord, Paclitaxel Ebewe
  • Luxembourg · Bugvi, Paclitaxel Accord Healthcare
  • Latvia · Paclitaxel Accord, Paclitaxel Kabi
  • Malta · Paclitaxel Accord Healthcare, Paclitaxel Hospira
  • Netherlands · Abutrax, Apacross
  • Norway · Abraxane, Apacross
  • Poland · Paclitaxel Ebewe, Paclitaxel Kabi
  • Portugal · Apacross, Paclitaxel Accord
  • Romania · Bugvi, Paclitaxel Accord
  • Sweden · Apacross, Bugvi
  • Slovenia · Alsicrosa, Paclitaxin
  • Slovakia · Paclitaxel Accord, Paclitaxel Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/53cb4b8b-af5a-4483-bbed-cbd6d7581f75
GET /v1/drugs/53cb4b8b-af5a-4483-bbed-cbd6d7581f75?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "6",
  "substance": "PACLITAXEL",
  "productndc": "0703-3216",
  "dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA075184",
  "marketing_category": "ANDA"
}

See everything about paclitaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.